Stay updated on Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- Check5 days agoChange DetectedThe NIH terminology-transition announcement was removed from the top of the page. The study page still displays a 403 error.SummaryDifference1%

- Check12 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0. The study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA banner announces NIH website transition updates and says some content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference1%

- Check26 days agoChange DetectedThe footer’s site revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error at the study URL, replacing the expected study record content. This indicates an access restriction preventing users from viewing the study details.SummaryDifference18%

Stay in the know with updates to Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.